ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,572.85
0.10%
US Tech 100
19,963.60
0.59%
Dow Jones
39,344.79
-0.08%
Brent Oil
85.495
0.09%
Bitcoin
57,405.22
1.23%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Ocugen Inc (OCGN) Quote

Ocugen Inc

Ocugen Inc (OCGN)

NASDAQ
1.745
0.035
(2.05%)
Closed July 09 4:00PM
Delayed by 15 minutes
1.73
-0.015
(-0.86%)
After Hours: 7:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.73
Bid
1.71
Ask
1.73
Volume
6,142,318
1.65 Day's Range 1.76
0.345 52 Week Range 2.105
Market Cap
440.031M
Previous Close
1.71
Open
1.69
Last Trade
6900
@
1.73
(formt)
Last Trade Time
Financial Volume
$ 10,503,869
VWAP
1.7101
Average Volume (3m)
6,723,259
Shares Outstanding
257,328,085
Dividend Yield
-
PE Ratio
-7.10
Earnings Per Share (EPS)
-0.25
Revenue
6.04M
Net Profit
-63.08M

About Ocugen Inc

Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal... Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug one to many and novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. The company is co-developing Bharat Biotech's COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Ortho,prosth,surg Appl,suply
Website
ocugen.com
Headquarters
Wilmington, Delaware, USA
Founded
2020
Ocugen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker OCGN. The last closing price for Ocugen was $1.71. Over the last year, Ocugen shares have traded in a share price range of $ 0.345 to $ 2.105.

Ocugen currently has 257,328,085 shares outstanding. The market capitalization of Ocugen is $440.03 million. Ocugen has a price to earnings ratio (PE ratio) of -7.10.

OCGN Latest News

More News

Form 8-K - Current report

10 hours ago
Edgar (US Regulatory)

Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease

•  Established Medium Dose as Safe and Tolerable Dose in Current OCU410ST Clinical Trial•  DSMB Determination to Proceed with High Dose Cohort Dosing MALVERN, Pa., June 21, 2024 (GLOBE...

June 21 2024
GlobeNewswire Inc.

Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication

MALVERN, Pa., June 20, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel...

June 20 2024
GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

June 18 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 06 2024
Edgar (US Regulatory)

Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy

Established Medium Dose as Safe and Tolerable Dose in Current OCU410 Clinical TrialDSMB Recommends Continuing with High-Dose Cohort Dosing with Concurrent Phase 2 Dosing MALVERN, Pa., May 31...

May 31 2024
GlobeNewswire Inc.

Ocugen to Present at BIO International Convention 2024

MALVERN, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...

May 29 2024
GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements

May 28 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.213.07189542481.531.761.4953828131.64350835CS
40.116.790123456791.621.761.1576049351.46577066CS
120.063.592814371261.672.061.1167232591.55094528CS
261.07162.1212121210.662.1050.490574966441.38506756CS
521.14193.2203389830.592.1050.34551546811.14092867CS
156-5.08-74.59618208526.8117.650.34592780494.82633713CS
260-1.51-46.60493827163.2418.770.17174119485.42750779CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SHPWShapeways Holdings Inc
$ 0.5041
(140.05%)
92.14M
ZAPPZapp Electric Vehicles Group Ltd
$ 9.25
(127.27%)
105.05M
IVPInspire Veterinary Partners Inc
$ 2.94
(97.32%)
54.79M
VRPXVirpax Pharmaceuticals Inc
$ 1.10
(90.31%)
161.22M
MORFMorphic Holding Inc
$ 55.71
(74.97%)
53.24M
HLVXHilleVax Inc
$ 1.63
(-88.41%)
25.64M
CLEUChina Liberal Education Holdings Ltd
$ 0.568999
(-73.90%)
15.69M
SYTSYLA Technologies Company Ltd
$ 2.07
(-31.91%)
534.24k
CJETChijet Motor Company Inc
$ 6.00
(-25.93%)
188.91k
WETHWetouch Technology Inc
$ 2.44
(-22.78%)
518.66k
MAXNMaxeon Solar Technologies Ltd
$ 0.2722
(13.42%)
493.51M
NVDANVIDIA Corporation
$ 128.20
(1.88%)
237.67M
VRPXVirpax Pharmaceuticals Inc
$ 1.10
(90.31%)
161.22M
TSLATesla Inc
$ 252.94
(0.56%)
157.27M
SVMHSRIVARU Holding Ltd
$ 0.1874
(17.94%)
121.48M

OCGN Discussion

View Posts
Monksdream Monksdream 3 days ago
OCGN under $2
👍️0
harry crumb harry crumb 2 weeks ago
Red continues, bagholders stuck, told everyone its junk
👍️0
harry crumb harry crumb 2 weeks ago
No partner or financing to move forward, no deals, no takers, if this science had meaning and worth, this would be at 5$ now!
👍️0
harry crumb harry crumb 2 weeks ago
The bleed to .25 continues, RS next, then offering, dilution coming imo, total scrapola company here
👍️0
harry crumb harry crumb 2 weeks ago
Ocujunk is getting even worse, perfect, stsy short til .25! Easy money from scrap scams like this
👍️0
vieuxcarre vieuxcarre 2 weeks ago
LOLOLOLOLOL
👍️0
harry crumb harry crumb 2 weeks ago
Be nice u brainless bozo
👍️0
vieuxcarre vieuxcarre 3 weeks ago
You’re the tird.
👍️0
harry crumb harry crumb 3 weeks ago
Down to 1$, then lower. This turd is running out of funds lol
👍️0
harry crumb harry crumb 1 month ago
The turd flounders again an again folks. This goes nowhere but down
👍️0
investingnotgambling investingnotgambling 1 month ago
OCGN ready to bounce off the 50 MA like at the beginning of the month? How about over $2 then keep going up into the summer. I’d like to quit my job to hang out with my wife and kids more, and OCGN will hopefully be my golden ticket.
👍️0
kingsransome kingsransome 1 month ago
pulled back on news of being added to Russell 3000 index in june
👍️0
harry crumb harry crumb 1 month ago
Ocgn scam, junk, falling knife, below 1$ soon enough
👍️0
Monksdream Monksdream 1 month ago
OCGN under $2
👍️0
Tradrdug17 Tradrdug17 1 month ago
That’s your opinion. You have no way of knowing that . I’m just saying, You keep making predictions and they don’t happen. You think you’re right, and then the stock proves you wrong. Those are facts. Just because you say it, Mr. hedge fund, doesn’t make it happen.
👍️0
shanak10 shanak10 2 months ago
Does anyone know what the lawsuit is about?
👍️0
vieuxcarre vieuxcarre 2 months ago
100%
👍️0
sgunderbarth sgunderbarth 2 months ago
Gm ocuhub. HOLDING.

OCGN
👍️0
vieuxcarre vieuxcarre 2 months ago
Moron
👍️0
harry crumb harry crumb 2 months ago
Down it goes again
👍️0
harry crumb harry crumb 2 months ago
We’ll c who gets the last vote for a fool my friend, they are running out of money! Expect this to be .25 soon enough
👍️0
Tradrdug17 Tradrdug17 2 months ago
Completion of clinical trial phase and earnings beati estimates. How is that not news? You make a fool out of yourself with every post. lol. It’s somewhat amusing
👍️0
vieuxcarre vieuxcarre 2 months ago
He’s a fraud.
👍️0
vieuxcarre vieuxcarre 2 months ago
We sure do
👍️0
sgunderbarth sgunderbarth 2 months ago
Holding

OCGN
👍️0
Tradrdug17 Tradrdug17 2 months ago
Lol you were on here two weeks ago, saying this would drop below a dollar then disappear. Why don’t you do everybody a favor and disappear
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
WE GOT A MAGGOT ON THE BOARD...WATCH AND LEARN!!!
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
OCGN...HERE WE GO!!!
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
OCGN..READY TO BREAK
👍️0
harry crumb harry crumb 2 months ago
Bah rah rah, short lived squeeze thats all, no news
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
OCGN let’s see that 2.16 break out
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
OCGN wants to fly here
👍️0
sgunderbarth sgunderbarth 2 months ago
Gm ocuhub.
👍️0
Monksdream Monksdream 2 months ago
OCGN under $2
👍️0
Monksdream Monksdream 2 months ago
OCGN under $2
👍️0
sgunderbarth sgunderbarth 2 months ago
OCGN pr. https://ir.ocugen.com/news-releases/news-release-details/ocugen-announces-cso-present-modifier-gene-therapy-retina-world
👍️0
harry crumb harry crumb 2 months ago
Stop, this turd is worthless
👍️0
vieuxcarre vieuxcarre 2 months ago
Watch your mama go under
👍️0
harry crumb harry crumb 2 months ago
1$, then under she goes for good! Watch an learn. $$$$$
👍️0
sgunderbarth sgunderbarth 2 months ago
Added this week and holding.

OCGN
👍️0
sgunderbarth sgunderbarth 2 months ago
That language doesn’t fly on ihub. Keep it clean and don’t risk getting booted.

Holding
👍️0
vieuxcarre vieuxcarre 3 months ago
Nope
👍️0
harry crumb harry crumb 3 months ago
Stop, really….
👍️0
harry crumb harry crumb 3 months ago
We’ll see 1$ again thats for sure imo
👍️0
harry crumb harry crumb 3 months ago
Stop, short it u’l make money $$$$$
👍️0
vieuxcarre vieuxcarre 3 months ago
Only thing bleeding is your mums puss lmoa
👍️0
vieuxcarre vieuxcarre 3 months ago
Learn to spell
👍️0
harry crumb harry crumb 3 months ago
Easy Money made again today, bleeding to under 1$ again folks, lets keep er going
👍️0
harry crumb harry crumb 3 months ago
Yur not right!
👍️0
investingnotgambling investingnotgambling 3 months ago
RSI at its lowest since early February when the 50 MA crossed the 200. Room to run here if buyers show up and the shorts start covering.
👍️0

Your Recent History

NASDAQ
OCGN
Ocugen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved